F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class

Thursday, August 27, 2015 - 23:00 in Health & Medicine

The new drug is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net